Skip to content

Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study

Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02657525
Acronym
AECOPD-IRS
Enrollment
7600
Registered
2016-01-18
Start date
2016-01-31
Completion date
2020-01-31
Last updated
2016-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

The purpose of this study is to investigate the demographic characteristics, clinical features, diagnoses and treatments of AECOPD hospitalized patients in China, and disease prognosis and its economic burden.

Interventions

None listed

Sponsors

Peking University
CollaboratorOTHER
China Soong Ching Ling Foundation
CollaboratorOTHER
China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

≥18 years of age; hospitalized patients with main diagnosis as AECOPD.

Exclusion criteria

Patients diagnosed as active pulmonary tuberculosis, or acute left heart failure; Patients participating in clinical trials or intervention studies of drugs.

Design outcomes

Primary

MeasureTime frameDescription
In-hospital mortality12 monthsAll-cause and cause-specific mortality will be described.
Readmission12 monthsReadmission rate caused by AECOPD within 1 month after discharged from hospital.

Secondary

MeasureTime frameDescription
All-cause and cause-specific mortality3 yearsAll-cause and cause-specific mortality will be described at different time points (1, 2, 3 years)
Recurrence of acute exacerbation of COPD3 yearsFrequency of AECOPD recurrence will be described during follow-ups, the date of first recurrence after discharge will be analysed.
Lung function and quality of life assessment3 yearsLung function will be measured regularly, quality of life will be assessed by questionnaires
Healthcare costs12 monthsDirect costs of hospital stay will be recorded.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026